钜泉科技: 钜泉光电科技（上海）股份有限公司2025年半年度报告摘要

Core Viewpoint - The financial performance of Jiuquan Optoelectronics Technology (Shanghai) Co., Ltd. for the first half of 2025 shows a decline in revenue and net profit compared to the previous year, indicating potential challenges in the company's operations and market conditions [1]. Financial Summary - Total assets at the end of the reporting period amounted to CNY 2,038.61 million, reflecting a 1.09% increase from CNY 2,016.68 million at the end of the previous year [1]. - The net assets attributable to shareholders decreased by 1.02%, from CNY 1,868.04 million to CNY 1,848.98 million [1]. - Operating revenue for the reporting period was CNY 272.08 million, down 11.39% from CNY 307.05 million in the same period last year [1]. - Total profit decreased by 43.90%, from CNY 53.16 million to CNY 29.83 million [1]. - Net profit attributable to shareholders fell by 33.34%, from CNY 56.23 million to CNY 37.49 million [1]. - The net cash flow from operating activities was negative at CNY -72.72 million, a significant decline from CNY 55.36 million in the previous year, representing a 231.36% decrease [1]. - The weighted average return on net assets decreased by 0.81 percentage points, from 2.79% to 1.98% [1]. - Basic earnings per share decreased by 30.50%, from CNY 0.4699 to CNY 0.3266 [1]. - Diluted earnings per share also decreased by 30.62%, from CNY 0.4689 to CNY 0.3253 [1]. R&D Investment - The proportion of R&D investment to operating revenue increased by 5.93 percentage points, from 27.43% to 33.36% [2]. Shareholder Information - As of the end of the reporting period, the total number of shareholders was 6,774 [2]. - The largest shareholder, Jiuquan Technology (Hong Kong) Limited, holds 17.54% of the shares, followed by Dongsheng Investment Limited with 10.83% [2]. Important Matters - The company is required to disclose significant changes in its operational situation during the reporting period and any matters that may have a substantial impact on its operations in the future [2].